The Stanford SPARK program supports the discovery and development of novel therapeutics and diagnostics that address unmet medical needs by offering funding, education and project-specific mentorship.
For innovators whose work has progressed towards developing solutions for specific commercial applications. The awards provide advisory support and funding to enable the move from research innovation to technology transfer or startup funding.
Sarafan ChEM-H is accepting applications from Stanford labs that would like to leverage the Chemoproteomics group at the Nucleus to advance therapeutic approaches in cancer, with a preference for EGFR-mutant lung cancer.
The Wu Tsai Human Performance Alliance invites proposals on athletic performance, injury prevention, and injury recovery to discover the biological principles that govern optimum performance, from the molecular level to the whole body.
Stanford HAI seeks proposals that support new, ambitious, and speculative ideas in AI with the objective of getting initial results. We expect to award approximately 25 grants, up to $75,000.
IAJS is accepting funding proposals up to $25,000 to support innovative research projects directly related to its mission. Funding will be given for early-stage research focusing on solutions to challenges related to racial and ethnic categorization, broadly defined.
The Stanford Beckman Center funds Technology Development seed grants for either: the development of new and improved instruments/devices or new methodologies to be used in biomedical research.
The Stanford Innovative Medicines Accelerator (IMA) is accepting proposals for projects that address two major challenges in small molecule drug discovery: adaptation of lab-grade assays to high- throughput screening (HTS) formats, and optimization of lead compounds into drug prototypes.
